Arno Therapeutics, Inc.
ARNI · OTC
12/31/2015 | 12/31/2014 | 12/31/2013 | 12/31/2012 | |
|---|---|---|---|---|
| Market Cap | $7,041 | $13,594 | $21,045 | $18,161 |
| - Cash | $67 | $7,948 | $26,774 | $10,943 |
| + Debt | $2,098 | $11 | $0 | $491 |
| Enterprise Value | $9,072 | $5,657 | -$5,729 | $7,709 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | -$8 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$13,397 | -$21,439 | -$16,910 | -$14,374 |
| % Margin | – | – | – | – |
| Net Income | -$11,536 | $7,771 | -$58,226 | -$20,749 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.57 | 0.31 | -7.75 | -4.57 |
| % Growth | -283.9% | 104% | -69.6% | – |
| Operating Cash Flow | -$9,966 | -$18,805 | -$14,243 | -$9,420 |
| Capital Expenditures | $0 | -$20 | $0 | $0 |
| Free Cash Flow | -$9,966 | -$18,826 | -$14,243 | -$9,420 |